Article detail · 2019
Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis
YÖKSİS
OpenAlex
SJR Q2
JCR Q2
Citations 22
Percentile 75.1%
FWCI 1.0
- Year
- 2019
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue PEDIATRIC DRUGS
- Catalog match (ISSN) Pediatric Drugs
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
22 citations
OpenAlex cited_by_count (cache / database)
13 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Familial Mediterranean Fever in Childhood 2024
- Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients 2018
- Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever? 2020
- The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study 2020
- The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study 2020
- THE REMARKABLE CHARACTERISTICS OF THE CHILDREN WITH COLCHICINE-RESISTANTA FAMILIAL MEDITERRANEAN FEVER IN TURKEY 2025
- The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey 2021
- Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR/PReS recommendations for familial Mediterranean fever 2025
- Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever 2022
- The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients 2021